Today’s Solutions: May 07, 2024

The next time you tweak your back, think twice before heading to the medicine cabinet. Acetaminophen, best known as the active ingredient in Tylenol, is the most popular drug in the world for treating low back pain. But a new study shows that it doesn’t help any more than a placebo, or inert sugar pill, for getting rid of the pain.

Researchers in Australia divided over 1,600 people with low back pain into three groups: regular dosing with acetaminophen, as-needed dosing, and dosing with a placebo. In addition to measuring how long it took for the participants’ back pain to clear up, they also measured overall pain levels and participants’ ability to function, sleep, and their quality of life. Across the board, they saw no differences between the three groups—taking acetaminophen regularly or only when in pain had no effect on how the participants felt or how long they needed to recover.

These findings, published in the prestigious Lancet medical journal, undermine existing medical guidelines—which recommend acetaminophen as the first-choice drug for back pain.

(Source: The Lancet, 2014; DOI: 10.1016/S0140-6736(14)60805-9)

Print this article
More of Today's Solutions

It’s kitten season! How to help overwhelmed shelters manage the influx of kit...

Kitten season has arrived, bringing with it an irresistible wave of feline cuteness. However, behind the scenes, animal rescues and shelters are dealing with ...

Read More

How to cut down on your food waste

Cutting down on food waste helps the environment in a number of important ways. Most obviously, it saves the resources and energy that go ...

Read More

How to keep an eye on your eye health

As we age, we can become more vulnerable to developing age-related eye conditions, diseases, and vision loss. The best way to stave off, or ...

Read More

CRISPR-Cas9 may be able to solve obesity

Cases of obesity have been steadily increasing worldwide, especially during the pandemic. Lack of physical activity through more office-based jobs, plus a lack of ...

Read More